Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors,
Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric
MATCH Treatment Trial)
Basic Study Information
Purpose:Location: University of Rochester
This phase II Pediatric MATCH trial studies how well vemurafenib works in treating
with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600 mutations
that have spread to other places in the body and have come back or do not respond
treatment. Vemurafenib may stop the growth of tumor cells by blocking some of the
needed for cell growth.
Study Contact InformationStudy Coordinator: Site Public Contact
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search